BackBenessere Capital Acquisition - Tradeable Rights - Jan 2021 Overview

Benessere Capital Acquisition - Tradeable Rights - Jan 2021 EBIT

Track Benessere Capital Acquisition - Tradeable Rights - Jan 2021's EBIT ($-3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$989.52K
336.47% YoY

As of Jun 30, 2022

Annual EBIT (TTM)

-$3.45M

Trailing 12 months ending Jun 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Benessere Capital Acquisition - Tradeable Rights - Jan 2021 (BENER) FAQ

The latest EBIT for BENER is $-3.5M as of June 2022. That is above the sector sector average of $-6.4M. Investors often review this figure alongside Benessere Capital Acquisition - Tradeable Rights - Jan 2021's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BENER currently prints $-3.5M for EBIT, while the sector average sits near $-6.4M. That is roughly 46.1% above the sector mean. Large gaps often invite a closer look at Benessere Capital Acquisition - Tradeable Rights - Jan 2021's growth, margins, and balance sheet.

A EBIT figure of $-3.5M for BENER is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting BENER's EBIT ($-3.5M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.